Abstract
Single oral doses of aluminium hydroxide (50 to 200 mg/kg) were found to induce in mice a dose-dependent diminution of the power of the 7.5 to 12 Hz frequency band, with a parallel dose-dependent increase of aluminium content in the brain, as early as 45 min after administration, and indicated that aluminium hydroxide is readily absorbed through an empty stomach or duodenum and is able to induce alterations of background EEG rhythms at doses equivalent to the ones used in human therapy. These data suggest that the EEG disturbances of the background type, (which are observed during the early stage of dialysis encephalopathy in man), may be partly due to a pharmacological and therefore reversible effect induced by an increase in aluminium level in the brain.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berlyne G. M., Yagil R., Ari J. B., Weinberger G., Knopf E., Danovitch G. M. Aluminium toxicity in rats. Lancet. 1972 Mar 11;1(7750):564–568. doi: 10.1016/s0140-6736(72)90357-1. [DOI] [PubMed] [Google Scholar]
- Bowdler N. C., Beasley D. S., Fritze E. C., Goulette A. M., Hatton J. D., Hession J., Ostman D. L., Rugg D. J., Schmittdiel C. J. Behavioral effects of aluminum ingestion on animal and human subjects. Pharmacol Biochem Behav. 1979 Apr;10(4):505–512. doi: 10.1016/0091-3057(79)90225-9. [DOI] [PubMed] [Google Scholar]
- Caroli S., Senofonte O., Delle Femmine P. Determination of trace elements in biological materials using a hollow-cathode discharge: comparative study of matrix effects. Analyst. 1983 Feb;108(1283):196–203. doi: 10.1039/an9830800196. [DOI] [PubMed] [Google Scholar]
- Chokroverty S., Bruetman M. E., Berger V., Reyes M. G. Progressive dialytic encephalopathy. J Neurol Neurosurg Psychiatry. 1976 May;39(5):411–419. doi: 10.1136/jnnp.39.5.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chokroverty S., Gandhi V. Electroencephalograms in patients with progressive dialytic encephalopathy. Clin Electroencephalogr. 1982 Apr;13(2):122–127. doi: 10.1177/155005948201300209. [DOI] [PubMed] [Google Scholar]
- Crapper D. R., Dalton A. J. Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention. Physiol Behav. 1973 May;10(5):935–945. doi: 10.1016/0031-9384(73)90064-4. [DOI] [PubMed] [Google Scholar]
- Crapper D. R. Experimental neurofibrillary degeneration and altered electrical activity. Electroencephalogr Clin Neurophysiol. 1973 Dec;35(6):575–588. doi: 10.1016/0013-4694(73)90211-3. [DOI] [PubMed] [Google Scholar]
- Crapper D. R., Tomko G. J. Neuronal correlates of an encephalopathy associated with aluminum neurofibrillary degeneration. Brain Res. 1975 Oct 31;97(2):253–264. doi: 10.1016/0006-8993(75)90448-5. [DOI] [PubMed] [Google Scholar]
- Farnell B. J., De Boni U., Crapper McLachlan D. R. Aluminum neurotoxicity in the absence of neurofibrillary degeneration in CA1 hippocampal pyramidal neurons in vitro. Exp Neurol. 1982 Nov;78(2):241–258. doi: 10.1016/0014-4886(82)90044-9. [DOI] [PubMed] [Google Scholar]
- GREEN J. D., ARDUINI A. A. Hippocampal electrical activity in arousal. J Neurophysiol. 1954 Nov;17(6):533–557. doi: 10.1152/jn.1954.17.6.533. [DOI] [PubMed] [Google Scholar]
- GREEN J. D. THE HIPPOCAMPUS. Physiol Rev. 1964 Oct;44:561–608. doi: 10.1152/physrev.1964.44.4.561. [DOI] [PubMed] [Google Scholar]
- Hughes J. R., Schreeder M. T. EEG in dialysis encephalopathy. Neurology. 1980 Nov;30(11):1148–1154. doi: 10.1212/wnl.30.11.1148. [DOI] [PubMed] [Google Scholar]
- KLATZO I., WISNIEWSKI H., STREICHER E. EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION. I. LIGHT MICROSCOPIC OBSERVATIONS. J Neuropathol Exp Neurol. 1965 Apr;24:187–199. doi: 10.1097/00005072-196504000-00002. [DOI] [PubMed] [Google Scholar]
- Kaehny W. D., Hegg A. P., Alfrey A. C. Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med. 1977 Jun 16;296(24):1389–1390. doi: 10.1056/NEJM197706162962407. [DOI] [PubMed] [Google Scholar]
- Nadel A. M., Wilson W. P. Dialysis encephalopathy: a possible seizure disorder. Neurology. 1976 Dec;26(12):1130–1134. doi: 10.1212/wnl.26.12.1130. [DOI] [PubMed] [Google Scholar]
- Sanderson C., McLachlan D. R., De Boni U. Inhibition of corticosterone binding in vitro, in rabbit hippocampus, by chromatin bound aluminum. Acta Neuropathol. 1982;57(4):249–254. doi: 10.1007/BF00692179. [DOI] [PubMed] [Google Scholar]
- Vanderwolf C. H. Hippocampal electrical activity and voluntary movement in the rat. Electroencephalogr Clin Neurophysiol. 1969 Apr;26(4):407–418. doi: 10.1016/0013-4694(69)90092-3. [DOI] [PubMed] [Google Scholar]
- Vecchierini-Blineau M. F., Thebaud H. E., Dupouet L., Brochard D., Coville P., Feve J. R., Guiheneuc P. Etude chronologique des signes de l'encéphalopathie myoclonique des hémodialysés. Signes précurseurs et évolution chez douze patients. Sem Hop. 1981 Nov 18;57(43-44):1823–1830. [PubMed] [Google Scholar]